DK129199B - Analogifremgangsmåde til fremstilling af 7-acylaminocephalosporansyrederivater eller ikke-toksiske salte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af 7-acylaminocephalosporansyrederivater eller ikke-toksiske salte deraf.

Info

Publication number
DK129199B
DK129199B DK253862AA DK253862A DK129199B DK 129199 B DK129199 B DK 129199B DK 253862A A DK253862A A DK 253862AA DK 253862 A DK253862 A DK 253862A DK 129199 B DK129199 B DK 129199B
Authority
DK
Denmark
Prior art keywords
preparation
acid derivatives
toxic salts
analogous process
acylaminocephalosporanic acid
Prior art date
Application number
DK253862AA
Other languages
English (en)
Other versions
DK129199C (da
Inventor
E Flynn
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK129199B publication Critical patent/DK129199B/da
Application granted granted Critical
Publication of DK129199C publication Critical patent/DK129199C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Fertilizing (AREA)
  • Shafts, Cranks, Connecting Bars, And Related Bearings (AREA)
DK253862AA 1961-06-08 1962-06-07 Analogifremgangsmåde til fremstilling af 7-acylaminocephalosporansyrederivater eller ikke-toksiske salte deraf. DK129199B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11561261A 1961-06-08 1961-06-08

Publications (2)

Publication Number Publication Date
DK129199B true DK129199B (da) 1974-09-09
DK129199C DK129199C (da) 1975-01-27

Family

ID=22362437

Family Applications (1)

Application Number Title Priority Date Filing Date
DK253862AA DK129199B (da) 1961-06-08 1962-06-07 Analogifremgangsmåde til fremstilling af 7-acylaminocephalosporansyrederivater eller ikke-toksiske salte deraf.

Country Status (14)

Country Link
BE (1) BE618663A (da)
BR (1) BR6239733D0 (da)
CA (1) CA984379A (da)
CH (1) CH409967A (da)
DE (2) DE1445701A1 (da)
DK (1) DK129199B (da)
ES (1) ES277871A1 (da)
FI (1) FI43597C (da)
FR (1) FR2899M (da)
GB (1) GB982252A (da)
LU (1) LU41846A1 (da)
NO (2) NO122749B (da)
OA (1) OA02701A (da)
SE (2) SE322513B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1082943A (en) * 1963-03-27 1967-09-13 Glaxo Lab Ltd Derivatives of 7-aminocephalosporanic acid
US3492297A (en) * 1965-07-01 1970-01-27 Merck & Co Inc Guanidino cephalosporins
GB1195203A (en) * 1966-06-24 1970-06-17 Glaxo Lab Ltd Cephalosporins

Also Published As

Publication number Publication date
GB982252A (en) 1965-02-03
NO122749B (da) 1971-08-09
ES277871A1 (es) 1962-12-01
OA02701A (fr) 1970-12-15
DE1445684A1 (de) 1968-12-05
FI43597C (fi) 1971-05-10
DE1445701A1 (de) 1969-08-28
DK129199C (da) 1975-01-27
LU41846A1 (da) 1962-12-07
FR2899M (fr) 1964-11-09
CH409967A (de) 1966-03-31
BE618663A (fr) 1962-12-14
BR6239733D0 (pt) 1973-06-14
NO133074C (da) 1976-03-03
SE357204B (da) 1973-06-18
SE322513B (da) 1970-04-13
NO133074B (da) 1975-11-24
FI43597B (da) 1971-02-01
CA984379A (en) 1976-02-24

Similar Documents

Publication Publication Date Title
DK115394B (da) Fremgangsmåde til fremstilling af fenylalkanderivater eller salte deraf.
DK103186C (da) Fremgangsmåde til fremstilling af alkoxypiperidinderivater eller salte deraf.
DK121231B (da) Fremgangsmåde til fremstilling af derivater af 7-aminocephalosporansyre eller salte deraf.
DK106036C (da) Fremgangsmåde til fremstilling af diphenylacetamid-derivater eller salte deraf.
DK106858C (da) Fremgangsmåde til fremstilling af N-acyl-N-hydroxyaminoaliphatiske syrer eller derivater eller salte heraf.
DK129199B (da) Analogifremgangsmåde til fremstilling af 7-acylaminocephalosporansyrederivater eller ikke-toksiske salte deraf.
DK128611B (da) Fremgangsmåde til fremstilling af derivater af cephalosporin C eller salte deraf.
DK106146C (da) Fremgangsmåde til fremstilling af aminoquinolinderivater eller syreadditionssalte deraf.
DK108152C (da) Fremgangsmåde til fremstilling af piperidylidenthioxanthenderivater eller syreadditionssalte deraf.
DK120595B (da) Fremgangsmåde til fremstilling af 6-aminopenicillansyrederivater eller salte heraf.
DK135506B (da) Analogifremgangsmåde til fremstilling af phentiazinderivater eller ikke-toksiske syreadditionssalte deraf.
DK106732C (da) Fremgangsmåde til fremstilling af dibenzocycloheptanderivater eller ikke-toksiske syreadditionssalte deraf.
DK102908C (da) Fremgangsmåde til fremstilling af derivater af tetrahydrodibenzocyloocten eller salte deraf.
DK97351C (da) Fremgangsmåde til fremstilling af dihydrolysergsyrederivater eller salte heraf.
DK101006C (da) Fremgangsmåde til fremstilling af β-carbolin-carboxylsyreamid-derivater eller salte deraf.
DK102190C (da) Fremgangsmåde til fremstilling af β-carbolin-carboxylsyreamid-derivater eller salte deraf.
DK104171C (da) Fremgangsmåde til fremstilling af morfantridinderivater eller syreadditionssalte heraf.
DK103077C (da) Fremgangsmåde til fremstilling af 4-hydroxyphenyl-4-carbalkoxy-piperidinderivater eller syreadditionssalte deraf.
DK105277C (da) Fremgangsmåde til fremstilling af 1-phenyl-2-alkylaminoalkanolderivater eller syreadditionssalte deraf.
DK102232C (da) Fremgangsmåde til fremstilling af alkoxypiperidinderivater eller salte deraf.
DK101790C (da) Fremgangsmåde til fremstilling af 4-sulfanilamidopyrimidinderivater eller salte deraf.
DK100616C (da) Fremgangsmåde til fremstilling af 4-phenylamino-quinolinderivater eller salte deraf.
DK102034C (da) Fremgangsmåde til fremstilling af 4-sulfanilamidopyrimidinderivater eller salte deraf.
DK102231C (da) Fremgangsmåde til fremstilling af alkoxypiperidinderivater eller salte deraf.
DK102631C (da) Fremgangsmåde til fremstilling af phenylalkanolaminderivater eller salte deraf.